The nation's top biotech analysts have looked over the field of presidential candidates and announced a big winner: Stem cell companies. All of the three major presidential candidates [1] have given their blessings to pumping up federal funding of research in the field--in a marked reversal to President Bush's steadfast [2] stand on restricting funds related to embryonic stem cell research.
"Any candidate is going to have a better policy on stem cells than our current president," Ren Benjamin, biotech analyst for Rodman & Renshaw, tells CNNMoney. "If that's the case, then it will be good news not only for the companies working in the space, but for the space in general."
- read the CNNMoney report [3]
Related Articles:
The 2008 Election: What does it mean for drugmakers? Report [1]
NIH chief breaks with Bush on stem cell research. Report [4]
Stem cell advance runs into conservative roadblock. Report [2]
Stem cell researchers dour after Bush veto. Report [5]
Links:
[1] http://www.fiercebiotech.com/story/2008-election-what-does-it-mean-drugmakers/2008-02-06
[2] http://www.fiercebiotech.com/story/stem-cell-advance-runs-into-conservative-roadblock/2006-08-25
[3] http://money.cnn.com/2008/02/26/news/companies/stem_cell/index.htm?postversion=2008022613
[4] http://www.fiercebioresearcher.com/story/nih-chief-breaks-with-bush-on-stem-cell-research/2007-03-20
[5] http://www.fiercebiotech.com/node/3540